311 related articles for article (PubMed ID: 23136067)
21. Advancements and perspectives of RBX2 as a molecular hallmark in cancer.
Tao Y; Dai L; Liang W; Li X; Lyu Y; Li J; Li Z; Shi Z; Liang X; Zhou S; Fu X; Hu W; Wang X
Gene; 2024 Jan; 892():147864. PubMed ID: 37820940
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid.
Tan M; Li Y; Yang R; Xi N; Sun Y
PLoS One; 2011; 6(11):e27726. PubMed ID: 22110742
[TBL] [Abstract][Full Text] [Related]
23. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model.
Zhang Q; Wei D; Tan M; Li H; Morgan MA; Sun Y
Neoplasia; 2020 Apr; 22(6):242-252. PubMed ID: 32339950
[TBL] [Abstract][Full Text] [Related]
24. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
[TBL] [Abstract][Full Text] [Related]
25. Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but antisense SAG transfection inhibits tumor cell growth.
Huang Y; Duan H; Sun Y
Mol Carcinog; 2001 Jan; 30(1):62-70. PubMed ID: 11255265
[TBL] [Abstract][Full Text] [Related]
26. Both Rbx1 and Rbx2 exhibit a functional role in the HIV-1 Vif-Cullin5 E3 ligase complex in vitro.
Wang X; Wang X; Wang W; Zhang J; Wang J; Wang C; Lv M; Zuo T; Liu D; Zhang H; Wu J; Yu B; Kong W; Wu H; Yu X
Biochem Biophys Res Commun; 2015 Jun; 461(4):624-9. PubMed ID: 25912140
[TBL] [Abstract][Full Text] [Related]
27. The Negative Cross-Talk between SAG/RBX2/ROC2 and APC/C E3 Ligases in Regulation of Cell Cycle Progression and Drug Resistance.
Zhang S; Shen Y; Li H; Bi C; Sun Y; Xiong X; Wei W; Sun Y
Cell Rep; 2020 Sep; 32(10):108102. PubMed ID: 32905768
[TBL] [Abstract][Full Text] [Related]
28. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
[TBL] [Abstract][Full Text] [Related]
29. Cullin RING Ligase 5 (CRL-5): Neddylation Activation and Biological Functions.
Zhang S; Sun Y
Adv Exp Med Biol; 2020; 1217():261-283. PubMed ID: 31898233
[TBL] [Abstract][Full Text] [Related]
30. Sag/Rbx2 Partial Inactivation Sensitizes Mice to Radiation and Radiation-Induced Tumorigenesis1.
Sun Y; Li H; Tan M; Sun Y
Radiat Res; 2023 Mar; 199(3):273-282. PubMed ID: 36745565
[TBL] [Abstract][Full Text] [Related]
31. An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases.
Huang T; Li J; Liu X; Shi B; Li S; An HX
Front Immunol; 2022; 13():968777. PubMed ID: 36059474
[TBL] [Abstract][Full Text] [Related]
32. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
33. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics.
Shafique S; Ali W; Kanwal S; Rashid S
Int J Biol Macromol; 2018 Jan; 106():532-543. PubMed ID: 28802844
[TBL] [Abstract][Full Text] [Related]
34. The SCF(HOS/beta-TRCP)-ROC1 E3 ubiquitin ligase utilizes two distinct domains within CUL1 for substrate targeting and ubiquitin ligation.
Wu K; Fuchs SY; Chen A; Tan P; Gomez C; Ronai Z; Pan ZQ
Mol Cell Biol; 2000 Feb; 20(4):1382-93. PubMed ID: 10648623
[TBL] [Abstract][Full Text] [Related]
35. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes.
Kohroki J; Nishiyama T; Nakamura T; Masuho Y
FEBS Lett; 2005 Dec; 579(30):6796-802. PubMed ID: 16325183
[TBL] [Abstract][Full Text] [Related]
36. SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.
Mathewson ND; Fujiwara H; Wu SR; Toubai T; Oravecz-Wilson K; Sun Y; Rossi C; Zajac C; Sun Y; Reddy P
Am J Pathol; 2016 Oct; 186(10):2679-91. PubMed ID: 27543965
[TBL] [Abstract][Full Text] [Related]
37. Cullin-RING Ligase 5: Functional characterization and its role in human cancers.
Zhao Y; Xiong X; Sun Y
Semin Cancer Biol; 2020 Dec; 67(Pt 2):61-79. PubMed ID: 32334051
[TBL] [Abstract][Full Text] [Related]
38. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase.
Pintard L; Willis JH; Willems A; Johnson JL; Srayko M; Kurz T; Glaser S; Mains PE; Tyers M; Bowerman B; Peter M
Nature; 2003 Sep; 425(6955):311-6. PubMed ID: 13679921
[TBL] [Abstract][Full Text] [Related]
39. CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.
He H; Tan M; Pamarthy D; Wang G; Ahmed K; Sun Y
Mol Cell Biochem; 2007 Jan; 295(1-2):179-88. PubMed ID: 16874460
[TBL] [Abstract][Full Text] [Related]
40. TRIM proteins as RING finger E3 ubiquitin ligases.
Ikeda K; Inoue S
Adv Exp Med Biol; 2012; 770():27-37. PubMed ID: 23630998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
